Health

DBV Technologies

DBV Technologies is a global clinical stage biopharmaceutical company developing innovative products for the diagnosis and treatment of food allergies
Industry
BioTech
Year invested
2003
Status
Dual IPO on Euronext (DBV) & Nasdaq (DBVT)
Active
Other investors
Sofinnova Partners, Apax Partners, InnoBio Fund, Lundbeckfonden
Location
France, US